Heini Honkanen appointed as Medaffcon’s Market Access Lead
Heini Honkanen has been appointed as Medaffcon’s Market Access Lead. The new Market Access Team was created when the previous Price and Reimbursement and HE & Access Teams were merged.
Health Economic Modelling
Modelling is an essential part of health economic analyses. It is a central tool for authorities, experts and payers to support decision-making regarding healthcare resource utilization.
Modelling is an essential part of health economic analyses. It is a central tool for authorities, experts and payers to support decision-making regarding healthcare resource utilization. With the help of modelling, fragmented research data, observations, and experiences, as well as justified assumptions, are compiled into a synthesis that aims to anticipate and predict the impact of healthcare interventions on individuals, patient groups, healthcare and society.
Modelling not only answers the decision maker’s question about the most likely outcome, but also the probability of extreme scenarios, as well as the credible range of results. In its most general form, modelling relates to the cost-effectiveness of an intervention. This means that the costs are examined together with the health benefits of the intervention. Another common target of modelling is the budget impact of an intervention. In this case, the focus is on the intervention’s impact on the use of resources. These can be even directly related to the intervention, or indirectly to the entire treatment path of a patient.
Medaffcon has the ability to complete modelling projects from the localization of the customer’s ready global core models to the comprehensive construction of models from the beginning. We have been doing modelling for over 10 years, providing our customers with an effective tool to support decision making.
“Modeling enables the combination of information from multiple sources and thus the evaluation of effectiveness and cost-effectiveness. The analysis can be based on any kind of information, such as the results of clinical trials or real world data.”
“The purpose of modelling is to provide tools for the clients and decision makers for managing and predicting future uncertainty. Modelling provides information for decision-making and for discussions with public authorities and healthcare payers.”
The final outcomes of the projects are for example used in:
- authority contexts
- negotiations with decision-makers and payers at different levels
- the support of sales and marketing, for example, in material production or tailor-made tools used in sales situations
Read more about our interactive value tools that combine health economic modelling, real world evidence and data science into one easy to use product.
Related articles
-
-
Greetings from ISPOR: the use of Real World Evidence is becoming more common
Medaffconin Tanja Nieminen ja Heini Honkanen osallistuivat terveystaloustieteen tutkimukseen ja terveydenhuollon menetelmien arviointiin keskittyvään ISPOR-kongressiin marraskuussa.
-
RWE complements the overall picture of the authorities
In health economic studies, real world evidence (RWE) can produce additional knowledge, especially on the…
